Slide 1: Interim Report for the first quarter 2026
2026 Interim Report for the first quarter January – March 2026 1 | OSSDSIGN AB | info@ossdsign.com | ossdsign.com
Slide 2: Interim Report for the first quarter of 2026
Interim Report for the first quarter of 2026 January 1 – March 31, 2026 The first quarter in figures • Net result for the period amounted to TSEK -11,473 (-14,577). • Net sales amounted to TSEK 36,879 (44,493), which • Earnings per share of SEK -0.1 (-0.1). translates to a decrease of 3.6% compared
Slide 3: CEO Statement: Reset: Laying the groundwork for accelerated growth
CEO Statement Reset: Laying the groundwork for accelerated growth I joined OssDsign as CEO in January, drawn by Catalyst’s strong clinical performance, the robustness of the underlying science, and the significant market opportunity in the U.S. These fundamentals remain firmly intact, and I am confi
Slide 4: Continuing to align and expand the commercial team
OssDsign continues to align and expand the commercial team, strengthening the sales foundation. Over the past 90 days, there has been excellent progress in identifying and hiring new commercial team members. The ramp-up for newly hired territory managers typically takes several months to translate i
Slide 5: OssDsign Catalyst – an off-the-shelf nanosynthetic bone graft
Statement of Operations OssDsign is a developer and provider of next generation orthobiologic products. Based on cutting edge material science, the company develops and markets products that support the body’s own healing capabilities, giving patients back the life they deserve. OssDsign Catalyst –
Slide 6: Development of profit and financial position
Development of profit and financial position FIRST QUARTER Sales and Gross margin The OssDsign Group net sales for the first quarter of 2026 Cash flow from investments of TSEK -6,012 (-1,305) was amounted to TSEK 36,879 (44,493), which translates to a decrease considerably higher than previous quart
Slide 7: Other Disclosures
OTHER DISCLOSURES Ownership structure long-term ability to become profitable and cash flow positive. Number Share Owners of shares Capital, % Transactions with related parties Försäkringsaktiebolaget Avanza Pension 11 755 889 10.6% The subsidiaries OssDsign USA Inc, OssDsign Ltd and Sirakoss Ltd inv
Slide 8: Condensed consolidated income statement
Condensed consolidated income statement 2026 2025 2025 SEK 000’ Jan 1 - Mar 31 Jan 1 - Mar 31 Jan 1 – Dec 31 Net sales 36 879 44 493 180 159 Cost of sales -3 104 -1 618 -6 691 Gross profit 33 775 42 875 173 468 Sales commissions and fees -17 364 -21 942 -87 484 Selling expenses -14 492 -11 756 -47 8
Slide 9: Condensed consolidated balance sheet
Condensed consolidated balance sheet 2026 2025 2025 SEK 000’ March 31 March 31 Dec 31 ASSETS Fixed assets Intangible assets 155 348 161 075 150 029 Tangible fixed assets 1 679 1 838 1 906 Financial assets 136 144 132 Total fixed assets 157 163 163 057 152 067 Current assets Inventories 21 140 16 049
Slide 10: Condensed consolidated change in shareholder's equity
Condensed consolidated change in shareholder’s equity Other Capital Profit (loss) Share Capital Reserves Total Equity Contributions brought forward SEK 000’ Opening balance 2025-01-01 6 104 796 024 30 843 -618 908 214 061 Profit/loss for the period – – – -14 577 -14 577 Other comprehensive income –
Slide 11: Condensed consolidated statement of cash flow
Condensed consolidated statement of cash flow 2026 2025 2025 SEK 000’ Jan 1 – Mar 31 Jan 1 – Mar 31 Jan 1 – Dec 31 Operating activities Operating result -13 466 -12 697 -46 757 Non cash adjustment 957 918 -788 Financial items 1 909 -1 976 -3 397 Income taxes paid/received -104 -108 -1 393 -10 705 -1
Slide 12: Condensed income statement, parent company
Condensed income statement, parent company 2026 2025 2025 SEK 000’ Jan 1 – Mar 31 Jan1 – Mar 31 Jan 1 – Dec 31 Net sales 6 936 10 386 25 023 Cost of goods sold -3 955 -4 376 -11 389 Gross profit 2 981 6 010 13 633 Sales commissions and fees -403 -832 -2 695 Selling expenses -474 -125 -1 041 R&D expe
Slide 13: Condensed balance sheet, parent company
Condensed balance sheet, parent company 2026 2025 2025 SEK 000’ Mar 31 Mar 31 Dec 31 ASSETS Fixed assets Financial assets 137 687 137 687 137 687 Total fixed assets 137 687 137 687 137 687 Current assets Inventories 18 665 13 193 20 563 Intercompany receivables 19 785 13 941 14 032 Tax receivable 46
Slide 14: Notes
Notes Note 1 | Accounting Principles NET SALES BY GEOGRAPHIC MARKET This summary interim report for the Group has been prepared in accordance with IAS 34 Interim Financial Reporting and Jan – Mar Jan – Dec applicable regulations in the Swedish Annual Accounts Act. The SEK 000’ 2026 2025 2025 interim
Slide 15: Signatures
Signatures The Board of Directors and the CEO provide their assurance that this interim report provides an accurate view of the operations, Financial calendar 2026 position and earning of the Group and the Parent Company, and that it also describes the principal risks and uncertainties faced by Annu
Slide 16: OssDsign AB contact details
OssDsign AB, Ulls väg 29C, 756 51 Uppsala, Sweden info@ossdsign.com ossdsign.com CONTACT Mark Waugh, CEO +1 260-804-1342 mark.waugh@ossdsign.com Anders Svensson, CFO +46(0)70-272 96 40 anders.svensson@ossdsign.com 16 | OSSDSIGN AB | info@ossdsign.com | ossdsign.com